A detailed history of Chiron Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Chiron Investment Management, LLC holds 10,752 shares of ABBV stock, worth $1.94 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
10,752
Holding current value
$1.94 Million
% of portfolio
0.75%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$163.84 - $199.33 $1.76 Million - $2.14 Million
10,752 New
10,752 $2.12 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $5.96 Million - $6.9 Million
44,625 New
44,625 $6.65 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $1.4 Million - $1.67 Million
-10,097 Reduced 97.84%
223 $36,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $1.39 Million - $1.59 Million
10,320 New
10,320 $1.39 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $18.5 Million - $20.6 Million
-208,202 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $397,815 - $470,705
4,431 Added 2.17%
208,202 $19.3 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $762,302 - $1.02 Million
8,285 Added 4.24%
203,771 $19.3 Million
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $6.56 Million - $7.19 Million
73,200 Added 59.86%
195,486 $18.9 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $1.58 Million - $2.02 Million
22,685 Added 22.78%
122,286 $10.9 Million
Q2 2017

Aug 15, 2017

SELL
N/A
-5,800 Reduced 5.5%
99,601 $7.22 Million
Q1 2017

Aug 15, 2017

BUY
N/A
105,401
105,401 $6.87 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Chiron Investment Management, LLC Portfolio

Follow Chiron Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Investment Management, LLC with notifications on news.